Why won’t the FDA let doctors prescribe fluvoxamine for COVID?

Wall Street Journal

30 May 2022 - Trials show it keeps patients from getting sicker, but the agency won’t approve its emergency use.

The FDA is under attack for being too cozy with drugmakers, but there’s nothing wrong with regulators cooperating with private industry. That’s how we got COVID-19 vaccines and therapies in record time.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Medicare , COVID-19